AIM
PFE icon

Acrospire Investment Management’s Pfizer PFE Stock Holding History

Acrospire Investment Management’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-6,219
Closed -$198K – 1040
2017
Q2 		$198K Buy
6,219
+4,006
+181% +$126K 0.19% 24
2017
Q1 		$72K Sell
2,213
-1,054
-32% -$33.2K 0.06% 594
2016
Q4 		$101K Buy
3,267
+1,686
+107% +$51.5K 0.04% 919
2016
Q3 		$51K Sell
1,581
-1,792
-53% -$59.9K 0.03% 1062
2016
Q2 		$113K Sell
3,373
-105
-3% -$3.35K 0.08% 347
2016
Q1 		$98K Buy
+3,478
New +$99.3K 0.07% 332

Other funds holding PFE

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Acrospire Investment Management's PFE Position: Q3 2017 in Review

Acrospire Investment Management sold out of Pfizer (PFE) in Q3 2017, closing a stake of 6,219 shares — an estimated $198K sold.

Acrospire Investment Management first reported a position in PFE in Q1 2016 and held it in 6 quarters. The position peaked at $198K in Q2 2017. 2,040 funds tracked by Wall St. Rank hold PFE as of Q3 2017.

  • Acrospire Investment Management reported no remaining Pfizer position as of Q3 2017 after selling out during the quarter.
  • Acrospire Investment Management sold 6,219 Pfizer shares in Q3 2017, an estimated $198K.
  • Acrospire Investment Management first reported a position in Pfizer in Q1 2016 and held it in 6 quarters.
  • Acrospire Investment Management's Pfizer position peaked at $198K in Q2 2017.
  • 2,040 funds tracked by Wall St. Rank held Pfizer as of Q3 2017.

Based on Acrospire Investment Management's 13F filing for Q3 2017, filed 26 Oct 2017.